Cocrystal Pharma, Inc. COCP
1.17
0.02
1.74%
as of 25 Sep
- Market cap
- $22.2M
- P/E
- 0.0×
Follow COCP
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
P/S ratio |
— | — | — | — | — | 37.27 | 2.43 | — | — | — |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
P/Operating CF |
— | — | — | — | — | (31.53) | (12.95) | — | — | — |
P/B ratio |
— | — | — | — | — | 1.43 | 0.62 | — | — | — |
Price to Tangible BV |
— | — | — | — | — | 2.25 | 2.41 | — | — | — |
EV/Sales |
— | — | — | — | — | 20.87 | 1.29 | — | — | — |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
— | — | — | — | — | (4.28) | (5.42) | — | — | — |
EV/FCF |
— | — | — | — | — | (4.17) | (4.96) | — | — | — |
Quick Ratio |
3.53 | 4.59 | 8.37 | 31.20 | 38.03 | 24.75 | 3.55 | 1.77 | 1.44 | 2.43 |
Current Ratio |
3.68 | 4.77 | 8.92 | 33.04 | 38.40 | 25.05 | 3.62 | 1.89 | 1.51 | 2.68 |
Net Debt/EBITDA |
0.82 | 0.57 | 1.32 | 1.92 | 4.25 | 3.57 | 3.64 | 0.04 | (0.03) | 0.03 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.14% | 0.01% | 0.06% | 0.05% | 0.17% | 0.83% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.14 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.93 | 0.94 | 0.82 | 0.55 | 0.90 | 1.02 | 0.03 | 0.17 | 11.26 | 0.20 |
Capex/Depreciation |
(0.03) | (0.02) | 0.09 | 0.00 | (0.14) | (0.71) | 0.00 | (0.56) | (0.40) | (0.25) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (111.40%) | (97.50%) | (54.54%) | (66.32%) | (21.81%) | (24.67%) | (104.04%) | (56.94%) | (0.59%) | (55.48%) | |
| (76.23%) | (78.29%) | (49.89%) | (64.60%) | (21.23%) | (23.31%) | (99.22%) | (51.63%) | (0.50%) | (42.89%) | |
ROIC |
0.00% | 0.00% | 0.00% | (1,009.07%) | (47.27%) | (30.76%) | (165.74%) | (61.21%) | (4.89%) | (67.02%) |
Return on Tangible Assets |
(146.77%) | (188.11%) | (68.90%) | (98.81%) | (24.36%) | (29.02%) | (749.60%) | (2,771.07%) | (71.45%) | (2,016.54%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | — | 100.76 | 35.81 | — | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 299.60% | 61.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 276.37% | 74.09% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.35 | 0.67 | 0.95 | 0.54 | 0.52 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 32.87% | 5.35% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | — | 0.43 | 0.34 | — | — | — |
Graham Number |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Earnings Yield |
— | — | — | — | — | (13.24%) | (302.12%) | — | — | — |
Free Cash Flow Yield |
— | — | — | — | — | (13.41%) | (10.73%) | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | 2.47 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.73) | (1.62) | (1.52) | (2.63) | (1.73) | (2.14) | (0.59) | (3.55) | (3.43) | (7.48) |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.01) | (0.01) | (0.05) | (0.05) | (0.01) | (0.02) | (0.03) |
Free Cash Flow per Share |
(0.73) | (1.62) | (1.53) | (2.64) | (1.73) | (2.19) | (0.64) | (3.57) | (3.45) | (7.51) |
Cash per Share |
0.63 | 0.98 | 2.74 | 4.57 | 7.98 | 7.19 | 2.81 | 1.18 | 0.39 | 1.86 |
Shareholders Equity per Share |
0.56 | 0.94 | 2.73 | 4.86 | 10.53 | 11.42 | 9.69 | 28.67 | 52.45 | 52.23 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.56 | 0.94 | 2.73 | 4.86 | 10.53 | 11.42 | 9.69 | 28.67 | 52.45 | 52.23 |
Free Cash Flow |
(8.20) | (16.49) | (14.78) | (21.51) | (12.77) | (10.07) | (1.71) | (8.32) | (6.94) | (14.71) |
Working Capital |
5.92 | 9.15 | 25.83 | 38.96 | 57.78 | 32.66 | 6.00 | 1.39 | 0.74 | 3.43 |
Capital Expenditures |
(0.01) | (0.01) | (0.12) | (0.07) | (0.05) | (0.24) | (0.14) | (0.03) | (0.04) | (0.05) |
Net Current Asset Value |
4.75 | 7.65 | 24.22 | 38.91 | 57.48 | 32.28 | 5.46 | 1.27 | (13.85) | (17.09) |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.02 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (479.05%) | (733.84%) | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
4.04 | 2.92 | (5.12) | 56.96 | 0.84 | 0.57 | 107.56 | 0.13 | 0.85 | 0.72 |
Cash ROIC |
(61.69%) | (85.51%) | (28.28%) | (28.34%) | (9.66%) | (12.17%) | (6.01%) | (12.43%) | (6.55%) | (14.10%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | 3.36 | 6.77 | — | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.96 | 1.05 | 0.80 | 0.64 | — | 0.60 | 0.97 | — | 1.30 | 0.76 |
Average Payables |
2.00 | 2.57 | 2.00 | 1.14 | 1.19 | 1.54 | 1.54 | 0.96 | 0.70 | 1.57 |
Average Assets |
11.58 | 22.36 | 36.05 | 60.12 | 66.82 | 41.39 | 48.55 | 94.99 | 123.15 | 174.56 |
Average Common Equity |
7.93 | 17.95 | 32.98 | 58.56 | 65.03 | 39.11 | 46.30 | 86.14 | 103.86 | 134.96 |
Columns are period end dates